1. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. Issue 10 (October 2020) Authors: Venter, Willem D F; Sokhela, Simiso; Simmons, Bryony; Moorhouse, Michelle; Fairlie, Lee; Mashabane, Nkuli; Serenata, Celicia; Akpomiemie, Godspower; Masenya, Masebole; Qavi, Ambar; Chandiwana, Nomathemba; McCann, Kaitlyn; Norris, Shane; Chersich, Matthew; Maartens, Gary; Lalla-Edward, Samanta; Vo... Journal: Lancet Issue: Volume 7:Issue 10(2020) Page Start: e666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial. (16th September 2021) Authors: Garcia-Prats, Anthony J; Svensson, Elin M; Winckler, Jana; Draper, Heather R; Fairlie, Lee; van der Laan, Louvina E; Masenya, Masebole; Schaaf, H Simon; Wiesner, Lubbe; Norman, Jennifer; Aarnoutse, Rob E; Karlsson, Mats O; Denti, Paolo; Hesseling, Anneke C Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 12(2021) Page Start: 3237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Issue 10269 (9th January 2021) Authors: Voysey, Merryn; Clemens, Sue Ann Costa; Madhi, Shabir A; Weckx, Lily Y; Folegatti, Pedro M; Aley, Parvinder K; Angus, Brian; Baillie, Vicky L; Barnabas, Shaun L; Bhorat, Qasim E; Bibi, Sagida; Briner, Carmen; Cicconi, Paola; Collins, Andrea M; Colin-Jones, Rachel; Cutland, Clare L; Darton, Thomas... Journal: Lancet Issue: Volume 397:Issue 10269(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Issue 9 (September 2021) Authors: Madhi, Shabir A; Koen, Anthonet L; Izu, Alane; Fairlie, Lee; Cutland, Clare L; Baillie, Vicky; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Aley, Parvinder K; Bhikha, Sutika; Hermanus, Tandile; Horne, Elizea; Jose, Aylin; Kgagudi, Prudence; Lamb... Journal: Lancet Issue: Volume 8:Issue 9(2021) Page Start: e568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Issue 10277 (6th March 2021) Authors: Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A; Weckx, Lily Y; Folegatti, Pedro M; Aley, Parvinder K; Angus, Brian; Baillie, Vicky L; Barnabas, Shaun L; Bhorat, Qasim E; Bibi, Sagida; Briner, Carmen; Cicconi, Paola; Clutterbuck, Elizabeth A; Collins, Andrea M; Cutland, Clare L; Darton, T... Journal: Lancet Issue: Volume 397:Issue 10277(2021) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir disoproxil fumarate/emtricitabine/efavirenz. (15th December 2021) Authors: Asif, Sumbul; Baxevanidi, Evangelia; Hill, Andrew; Venter, Willem Daniel Francois; Fairlie, Lee; Masenya, Masebole; Serenata, Celicia; Sokhela, Simiso; Chandiwana, Nomathemba Journal: AIDS Issue: Volume 35:Supplement 2(2021) Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir disoproxil fumarate/emtricitabine/efavirenz. (15th December 2021) Authors: Asif, Sumbul; Baxevanidi, Evangelia; Hill, Andrew; Venter, Willem Daniel Francois; Fairlie, Lee; Masenya, Masebole; Serenata, Celicia; Sokhela, Simiso; Chandiwana, Nomathemba Journal: AIDS Issue: Volume 35:Supplement 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗